Identifying Rare Dermatologic Disorders in the Critical Care Setting : Episode 10

Video

May 26, 2023

Spesolimab for Treatment of GPP

Author(s):

Raj Chovatiya, MD, PhD,Boni Elewski, MD

Experts discuss spesolimab, an IL-36 inhibitor, that was recently FDA approved for treatment of GPP.

EP: 1.Prevalence of Rare Dermatological Disorders

EP: 2.Symptoms of Rare Dermatological Disorders

EP: 3.Pathophysiology of GPP, PPP, and SJS

EP: 4.GPP, PPP and SJS: Typical Patient Journey

EP: 5.Diagnosis of Rare Dermatological Disorders

EP: 6.Differential Diagnosis of Rare Skin Conditions

EP: 7.Challenges in Managing Rare Skin Conditions

EP: 8.Initial Management Of Patients With Rare Dermatological Disorders

EP: 9.Use of Biologics in Rare Dermatologic Disorders

EP: 10.Spesolimab for Treatment of GPP

EP: 11.Future Treatment Outlook for Rare Dermatological Disorders

EP: 12.Improving Recognition and Referral of Rare Conditions in Rare Setting

EP: 13.Patient Subgroups and Educational Opportunities in Rare Dermatological Disorders

EP: 14.Recommendations for Management of Rare Dermatological Disorders in Critical Care Setting

Related Videos

AI in Dermatology: Emerging Insights and Diverging Perspectives

Skin of Color Savvy: News Update—Addressing Disparities, Black History Month, & Mentorship Opportunities

Medical Sisterhood: James Del Rosso, DO

Understanding Angioedema in Urticaria, with Jonathan Bernstein, MD

Importance of Birch Triterpene Findings for Epidermolysis Bullosa, with Anna Bruckner, MD

Phase 3 Findings on Birch Triterpenes for Epidermolysis Bullosa, with Anna Bruckner, MD

Impact of Tapinarof Cream Approval for Atopic Dermatitis, with Adelaide Hebert, MD

Skin of Color Savvy: The Art and Science of Treating Patients of Color

Crisis Point: Benzene Concerns in Acne Care

Related Content

Related Content

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.